This is a demo store. No orders will be fulfilled.

Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 20 Jun 2014  |  Global  |  Market Research

    Global Next-generation Sequencing Market

    On the Verge of a Quadrupled Competitor Size and a Clinical Turning Point

    The total market, as defined by this study, includes next-generation sequencing instruments and reagents. Instruments include those that use newer technology than traditional capillary electrophoresis (CE) sequencing, such as sequencing-by-synthesis, sequencing-by-ligation, single-molecule sequencing, and semiconductor sequencing. This research ser...

    $10,000.00
  2. 11 Jun 2014  |  Global  |  Market Research

    Analysis of the Western European Next Generation Sequencing (NGS) Market

    Clinical Applications Grow, Regulations Stiffen, Acquisitions Mount

    This research service focuses on antiviral/antiretroviral therapeutics for the treatment of HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HIV infection. Segmentation by drug class is provided along with additional supporting information such as clinica...

    $4,950.00
  3. 02 Jun 2014  |  Global  |  Market Research

    Vital Signs - Healthcare News - The Analysts Perspective - May Issue

    This issue of Vital Signs, released on June 2, 2014, discusses the latest strategy surrounding mega deals in the pharma/biotech industry, Eurofins agreement to acquire ViroCor-IBT Laboratories, Qiagens acquisition of BIOBASE, and the FDAs latest announcement on regulatory requirements for biosimilars.

    $450.00
  4. 28 May 2014  |  Asia Pacific  |  Market Research

    Profiling of Top 50 Healthcare Service Providers in Asia-Pacific

    A Deep-dive Analysis of the Business and Financial Health of Leading Companies in the Region

    Increased competition between healthcare providers which has lead to increased development of competitive features, such as premium care facilities, aesthetic and wellness medicine facilities, improved patient customer service, and so on. This has also stimulated the increased application of technology in both medical devices and information and c...

    $4,950.00
  5. 26 May 2014  |  Asia Pacific  |  Market Research

    Indonesian Infectious Disease IVD Market

    Mapping the Market for Investment, Best Practices, and Growth Potential

    The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and p...

    $4,950.00
  6. 23 May 2014  |  Asia Pacific  |  Market Research

    Western European Companion Diagnostics Market

    Regulatory Hurdles and LDTs Stall the Global and European Market for Companion Diagnostics

    The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a signi...

    $4,950.00
  7. 20 May 2014  |  Asia Pacific  |  Market Research

    Russia In Vitro Diagnostics (IVD) Market Data

    Early Detection Provides New Opportunities for IVD Industry

    This study provides data for the Russian in vitro diagnostics (IVD) market. Hematology, hemostasis (coagulation), urinalysis, microbiology, clinical chemistry, point of care testing, molecular diagnostics, immunochemistry, and others namely, tissue diagnostics and self-monitoring blood glucose, are the segments discussed in this market. Market reve...

    $3,950.00
  8. 05 May 2014  |  Asia Pacific  |  Market Research

    Russia Hematology Diagnostics Market Data

    Russian Governments Support for Development of In Vitro Diagnostic Industry Propels Adoption of High End Analyzers

    This study provides market data for the Russian hematology diagnostics market. Segments in the market include instruments and reagents. Instruments are further segmented by 5PD and 3PD analyzers. Market revenues, installed base units, and market share are included in this deliverable. Further analysis is provided in a separate deliverable to accomp...

    $3,950.00
  9. 05 May 2014  |  Asia Pacific  |  Market Research

    Russia Urinalysis Market Data

    Increase in Test Volume Creates a Favorable Market for Reagents

    This study provides market data for the Russian urinalysis market. Market segments include sediment, dipstick, and integrated systems. Sediment and dipstick segments are further segmented by instruments and reagents. Integrated systems is further segmented by instruments. In this deliverable, market revenues, installed base units, and market share ...

    $3,950.00
  10. 05 May 2014  |  Asia Pacific  |  Market Research

    Russia Hemostasis Market Data

    Russian Governments Intensive Support for Development of the In vitro Diagnostics Industry Propels Adoption of High-end Analyzers

    This study provides market data for the Russian hemostasis diagnostics market. Market segments include instruments and reagents. The study also includes market revenues, installed base units, and market share for hemostasis diagnostics. Further analysis is provided in a separate deliverable to accompany this data. The timeframe for this study is 20...

    $3,950.00